» Articles » PMID: 38784787

Interstitial Cystitis-an Imbalance of Risk and Protective Factors?

Overview
Date 2024 May 24
PMID 38784787
Authors
Affiliations
Soon will be listed here.
Abstract

Interstitial cystitis (IC) presents as a chronic pain condition with variable combinations of symptoms depending on the species and individual patient. It is diagnosed by the presence of lower urinary tract signs and symptoms in combination with a variety of comorbid health problems, a history of life adversities, and the absence of other conditions that could cause the lower urinary tract signs. IC occurs naturally in humans and cats as a dimensional condition, with patients presenting with mild, moderate, and severe symptoms. Most patients appear to recover without specific treatment. A number of rodent models of IC have been used to study its causes and treatments. Unfortunately, current therapies generally fail to ameliorate IC symptoms long-term. The recent classification of IC as a chronic pain disorder calls for a rethinking of current clinical and research approaches to it. Beginning when a patient encounters a clinician, precipitating, perpetuating, and palliating risk factors can be addressed until a cause or reliably effective therapy is identified, and identifying predisposing and preventive factors can inform epidemiological studies and health promotion interventions. Predisposing, precipitating, and perpetuating risk factors, including environmental, psychological, and biological, increase the activity of the central threat response system (CTRS), which plays a clinically important role in IC symptoms. Studies in cats and rodent models have revealed that environmental enrichment (EE), in the absence of bladder-directed therapies, leads to amelioration of IC symptoms, implying a central role for the CTRS in symptom precipitation and perpetuation. Conceptually moving the source of IC pain to the brain as a motivational state rather than one resulting from peripheral nociceptive input offers both clinicians and researchers novel opportunities to improve care for patients with IC and for researchers to use more ecologically valid rodent models. It may even be that IC results from an excess of risk to protective factors, making this imbalance a targetable cause rather than a consequence of IC.

Citing Articles

2025 iCatCare consensus guidelines on the diagnosis and management of lower urinary tract diseases in cats.

Taylor S, Boysen S, Buffington T, Chalhoub S, Defauw P, Delgado M J Feline Med Surg. 2025; 27(2):1098612X241309176.

PMID: 39935081 PMC: 11816079. DOI: 10.1177/1098612X241309176.

References
1.
Sculptoreanu A, de Groat W, Buffington C, Birder L . Abnormal excitability in capsaicin-responsive DRG neurons from cats with feline interstitial cystitis. Exp Neurol. 2005; 193(2):437-43. DOI: 10.1016/j.expneurol.2005.01.011. View

2.
Parys M, Yuzbasiyan-Gurkan V, Kruger J . Serum Cytokine Profiling in Cats with Acute Idiopathic Cystitis. J Vet Intern Med. 2018; 32(1):274-279. PMC: 5787166. DOI: 10.1111/jvim.15032. View

3.
He C, Fan K, Hao Z, Tang N, Li G, Wang S . Prevalence, Risk Factors, Pathophysiology, Potential Biomarkers and Management of Feline Idiopathic Cystitis: An Update Review. Front Vet Sci. 2022; 9:900847. PMC: 9257190. DOI: 10.3389/fvets.2022.900847. View

4.
Twiss C, Kilpatrick L, Craske M, Buffington C, Ornitz E, Rodriguez L . Increased startle responses in interstitial cystitis: evidence for central hyperresponsiveness to visceral related threat. J Urol. 2009; 181(5):2127-33. PMC: 3094570. DOI: 10.1016/j.juro.2009.01.025. View

5.
West E, Sellers D, Chess-Williams R, McDermott C . Voiding Behavior and Efferent Bladder Function Altered in Mice Following Social Defeat but Not Witness Trauma. Front Physiol. 2020; 11:247. PMC: 7098992. DOI: 10.3389/fphys.2020.00247. View